/

Empresas

Ca

No verificado

Camurus AB

Sobre qué escribimos

EconomíaFarmacéuticaFitnessSaludSanidad

5 Comunicados de prensa

Ver todos los comunicados de prensa

01/07/2025

Salud

Fitness

Medicina - Varios

Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU

Fuente

Editor

1.00

0

03/06/2025

Farmacéutica

Sanidad

Economía

Patentes, marcas y derechos de autor

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

Fuente

Editor

1.00

0

25/04/2025

Farmacéutica

Sanidad

Biología

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU

Fuente

Editor

1.00

0

15/07/2024

Farmacéutica

Sanidad

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

Fuente

Editor

1.00

0

25/06/2024

Farmacéutica

Sanidad

New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0